Stocktoria

Oruka Therapeutics, Inc. ORKA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2000-07-21

Oruka Therapeutics, Inc. statistics & valuation

Market cap$5.5B
P / B11.6×
Return on equity-22.3%
Return on capital-25.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2015201620172018201920202021202220232025
Operating margin (%)
2015201620172018201920202021202220232025
Return on equity (%)
-30.10% -74.10% -180.00% -131.50% -72.00% -20.90% -37.90% -23.80% -14.40% -22.30% 2015201620172018201920202021202220232025
Shares outstanding
9.1M 9.1M 11.8M 773558 1.6M 9.5M 14.4M 14.4M 14.5M 48.7M 2015201620172018201920202021202220232025
Net debt ($)
2015201620172018201920202021202220232025
Share buybacks ($)
2015201620172018201920202021202220232025
Return on assets (%)
-28.90% -66.80% -149.50% -116.20% -64.20% -19.30% -35.20% -23.00% -14.10% -21.60% 2015201620172018201920202021202220232025
Free cash flow margin (%)
2015201620172018201920202021202220232025
Debt / equity (×)
2015201620172018201920202021202220232025
EPS ($)
-$1.39 -$0.69 -$0.37 2015201620172018201920202021202220232025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Return on assets-21.6%-14.1%-23.0%-35.2%-19.3%-64.2%-116.2%-149.5%-66.8%-28.9%
Return on equity-22.3%-14.4%-23.8%-37.9%-20.9%-72.0%-131.5%-180.0%-74.1%-30.1%
Current ratio22.3759.0137.7215.5614.289.168.555.948.9525.88

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.